| Literature DB >> 28553665 |
Antonio J Signes-Pastor1, Manus Carey1, Jesus Vioque2,3, Eva M Navarrete-Muñoz2,3, Cristina Rodríguez-Dehli4, Adonina Tardón4,3, Miren Begoña-Zubero5,6, Loreto Santa-Marina6,3, Martine Vrijheid7,3,8, Maribel Casas7,3, Sabrina Llop9,3, Sandra Gonzalez-Palacios2, Andrew A Meharg1.
Abstract
Inorganic arsenic (i-As) is a non-threshold human carcinogen that has been associated with several adverse health outcomes. Exposure to i-As is of particular concern among pregnant women, infants and children, as they are specifically vulnerable to the adverse health effects of i-As, and in utero and early-life exposure, even low to moderate levels of i-As, may have a marked effect throughout the lifespan. Ion chromatography-mass spectrometry detection (IC-ICP-MS) was used to analyse urinary arsenic speciation, as an exposure biomarker, in samples of 4-year-old children with relatively low-level arsenic exposure living in different regions in Spain including Asturias, Gipuzkoa, Sabadell and Valencia. The profile of arsenic metabolites in urine was also determined in samples taken during pregnancy (1st trimester) and in the children from Valencia of 7 years old. The median of the main arsenic species found in the 4-year-old children was 9.71 μg/l (arsenobetaine-AsB), 3.97 μg/l (dimethylarsinic acid-DMA), 0.44 μg/l (monomethylarsonic acid-MMA) and 0.35 μg/l (i-As). Statistically significant differences were found in urinary AsB, MMA and i-As according to the study regions in the 4-year-old, and also in DMA among pregnant women and their children. Spearman's correlation coefficient among urinary arsenic metabolites was calculated, and, in general, a strong methylation capacity to methylate i-As to MMA was observed.Entities:
Keywords: Arsenic speciation; Biomarker; Children; Inorganic arsenic; Pregnant women; Urinary metabolites
Year: 2016 PMID: 28553665 PMCID: PMC5425496 DOI: 10.1007/s12403-016-0225-7
Source DB: PubMed Journal: Expo Health ISSN: 2451-9766 Impact factor: 11.422
Fig. 1Geographical location of the cohorts in Spain included in this study
Arsenic speciation (median [25–75 %ile]) in urinary pregnant women, 4-year-old and 7 year-old children samples from each cohort study
| Category | N | AsB (μg/l) | DMA (μg/l) | MMA (μg/l) | i-As (μg/l) |
|---|---|---|---|---|---|
| Children—4 years | 400 | 9.71 (2.58–34.92)A | 3.97 (2.06-6.20) | 0.44 (0.25-0.69) | 0.35 (0.21-0.56) |
| Girls—4-year-old | 200 | 9.21 (2.44-28.25) | 3.82 (1.85-6.13) | 0.40 (0.24-0.69) | 0.32 (0.21–0.57) |
| Boys—4-year-old | 200 | 10.51 (2.89–40.41) | 4.07 (1.85–6.27) | 0.45 (0.25–0.70) | 0.37 (0.21–0.56) |
|
| 0.778 | 0.376 | 0.568 | 0.796 | |
| Asturias—4-year–old | 100 | 9.07 (1.68–25.31)b | 3.76 (2.19–5.67) | 0.35 (0.18–0.60)b | 0.38 (0.25–0.54)a |
| Gipuzkoa—4-year-old | 100 | 16.32 (6.25–54.64)a | 4.23 (2.27–8.92) | 0.52 (0.37–0.79)a | 0.22 (0.13–0.37)b |
| Sabadell—4-year-old | 100 | 5.72 (1.74–20.49)b | 3.73 (1.62–5.45) | 0.49 (0.25–0.84)ab | 0.39 (0.23–0.65)a |
| Valencia—4-year-old | 100 | 9.01 (2.43–48.78)ab | 4.19 (2.34–6.39) | 0.36 (0.22–0.60)b | 0.44 (0.28–0.59)a |
|
| <0.001 | 0.131 | <0.001 | <0.001 | |
| 4-year-old-valencia | 100 | 9.01 (2.43–48.78) | 4.19 (2.34–6.39)b | 0.36 (0.22–0.60) | 0.44 (0.28–0.59) |
| 7-year-old-valencia | 100 | 6.81 (1.63–27.61) | 4.14 (2.57–6.49)b | 0.35 (0.22–0.50) | 0.40 (0.23–0.57) |
| Pregnant women-valencia | 100 | 11.96 (4.14–50.34) | 5.69 (2.93–10.89)a | 0.32 (0.19–0.63) | 0.42 (0.27–0.62) |
|
| 0.115 | 0.003 | 0.594 | 0.518 |
AMedian (25–75 %ile); values with the same letters were not significantly different at p-value <0.05 for the variable studied
Fig. 2Correlation between arsenic species in urinary 4-year-old samples from each cohort study
Fig. 3Correlation between arsenic species in urinary pregnant women and 7-year-old children samples from Valencia